Prestige Consumer Healthcare Inc.

NYSE:PBH Stok Raporu

Piyasa değeri: US$3.9b

Prestige Consumer Healthcare Yönetim

Yönetim kriter kontrolleri 4/4

Prestige Consumer Healthcare CEO'su Ron Lombardi, Jun2015 tarihinde atandı, in görev süresi 9.5 yıldır. in toplam yıllık tazminatı $ 5.76M olup, şirket hissesi ve opsiyonları dahil olmak üzere 17.4% maaş ve 82.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.59% ine doğrudan sahiptir ve bu hisseler $ 22.92M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.4 yıl ve 4.6 yıldır.

Anahtar bilgiler

Ron Lombardi

İcra Kurulu Başkanı

US$5.8m

Toplam tazminat

CEO maaş yüzdesi17.4%
CEO görev süresi9.5yrs
CEO sahipliği0.6%
Yönetim ortalama görev süresi7.4yrs
Yönetim Kurulu ortalama görev süresi4.6yrs

Son yönetim güncellemeleri

Recent updates

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Dec 04
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

CEO Tazminat Analizi

Ron Lombardi'un ücretlendirmesi Prestige Consumer Healthcare'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

US$206m

Jun 30 2024n/an/a

US$205m

Mar 31 2024US$6mUS$1m

US$209m

Dec 31 2023n/an/a

-US$81m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$84m

Mar 31 2023US$6mUS$1m

-US$82m

Dec 31 2022n/an/a

US$210m

Sep 30 2022n/an/a

US$209m

Jun 30 2022n/an/a

US$203m

Mar 31 2022US$6mUS$937k

US$205m

Dec 31 2021n/an/a

US$189m

Sep 30 2021n/an/a

US$179m

Jun 30 2021n/an/a

US$179m

Mar 31 2021US$5mUS$888k

US$165m

Dec 31 2020n/an/a

US$166m

Sep 30 2020n/an/a

US$163m

Jun 30 2020n/an/a

US$152m

Mar 31 2020US$5mUS$875k

US$142m

Dec 31 2019n/an/a

-US$34m

Sep 30 2019n/an/a

-US$34m

Jun 30 2019n/an/a

-US$36m

Mar 31 2019US$4mUS$850k

-US$36m

Dec 31 2018n/an/a

US$64m

Sep 30 2018n/an/a

US$340m

Jun 30 2018n/an/a

US$340m

Mar 31 2018US$4mUS$850k

US$340m

Tazminat ve Piyasa: Ron 'ın toplam tazminatı ($USD 5.76M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 6.65M ).

Tazminat ve Kazançlar: Ron 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Ron Lombardi (60 yo)

9.5yrs

Görev süresi

US$5,763,133

Tazminat

Mr. Ronald M. Lombardi, also known as Ron, served as a Director at Consumer Healthcare Products Association. He has been the Chief Executive Officer and President of Prestige Brands Holdings, Inc. (now Pre...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Ronald Lombardi
Chairman9.5yrsUS$5.76m0.59%
$ 22.9m
Christine Sacco
Chief Financial Officer8.3yrsUS$2.00m0.036%
$ 1.4m
Jeffrey Zerillo
Senior Vice President of Operations6.7yrsUS$862.93k0.064%
$ 2.5m
William P'Pool
Senior VP8.1yrsUS$1.34m0.026%
$ 1.0m
Adel Mekhail
Executive Vice President of Marketing & Sales5.6yrsUS$1.32m0.024%
$ 952.5k
Philip Terpolilli
Director of Investor Relationsno dataVeri yokVeri yok
Dean Siegal
Director of Communicationsno dataVeri yokVeri yok
Mary Fritz
Senior Vice President of Quality & Regulatory Affairs6.5yrsVeri yok0.030%
$ 1.2m

7.4yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: PBH 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.4 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Ronald Lombardi
Chairman9.5yrsUS$5.76m0.59%
$ 22.9m
John Byom
Lead Independent Director18.9yrsUS$273.33k0.097%
$ 3.8m
Clesteen Clark
Independent Director3.8yrsUS$257.08k0.014%
$ 546.4k
Dawn Zier
Independent Director4.6yrsUS$260.63k0.020%
$ 782.5k
Sheila Hopkins
Independent Director9.3yrsUS$243.33k0.048%
$ 1.9m
James D'Arecca
Independent Director1.3yrsUS$197.92kVeri yok
John Kelly
Independent Directorless than a yearVeri yokVeri yok

4.6yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PBH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.6 yıldır).


Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2024/12/22 17:48
Gün Sonu Hisse Fiyatı2024/12/20 00:00
Kazançlar2024/09/30
Yıllık Kazançlar2024/03/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Prestige Consumer Healthcare Inc. 16 Bu analistlerden 8, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Olivia Tong CheangBofA Global Research
Linda Bolton-WeiserB. Riley Securities, Inc.
Susan AndersonCanaccord Genuity